RemedyRepack Inc. recalls Clindamycin HCl
- Published
- 30 Apr 2025
- Units affected
- 1,858 30-count blister cards
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00
- Brand / company
- RemedyRepack Inc.
- Codes / lots
- Lot J0826722-121624 Exp. 12/31/2025 Lot J0820365-111324 Exp. 11/30/2025 Lot J0814691-101624 Exp. 10/31/2025
- Distribution
- PA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 30 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.